Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.


Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
11 2019
Historique:
received: 05 07 2019
accepted: 07 08 2019
pubmed: 8 10 2019
medline: 17 6 2020
entrez: 8 10 2019
Statut: ppublish

Résumé

Thrombotic thrombocytopenic purpura (TTP) is fatal in 90% of patients if left untreated and must be diagnosed early to optimize patient outcomes. However, the very low incidence of TTP is an obstacle to the development of evidence-based clinical practice recommendations, and the very wide variability in survival rates across centers may be partly ascribable to differences in management strategies due to insufficient guidance. We therefore developed an expert statement to provide trustworthy guidance about the management of critically ill patients with TTP. As strong evidence was difficult to find in the literature, consensus building among experts could not be reported for most of the items. This expert statement is timely given the recent advances in the treatment of TTP, such as the use of rituximab and of the recently licensed drug caplacizumab, whose benefits will be maximized if the other components of the management strategy follow a standardized pattern. Finally, unanswered questions are identified as topics of future research on TTP.

Identifiants

pubmed: 31588978
doi: 10.1007/s00134-019-05736-5
pii: 10.1007/s00134-019-05736-5
doi:

Substances chimiques

Adrenal Cortex Hormones 0
ADAMTS13 Protein EC 3.4.24.87
ADAMTS13 protein, human EC 3.4.24.87

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1518-1539

Commentaires et corrections

Type : ErratumIn

Références

Ann Intern Med. 1979 Sep;91(3):357-63
pubmed: 573083
N Engl J Med. 2013 Jan 3;368(1):90-2
pubmed: 23281998
Blood. 2005 Sep 15;106(6):1932-7
pubmed: 15933059
Ther Apher Dial. 2004 Jun;8(3):254-7
pubmed: 15154880
Transfusion. 2008 Feb;48(2):382-92
pubmed: 18028268
Am J Hematol. 2011 Sep;86(9):743-51
pubmed: 21850657
Am J Med. 1987 Sep;83(3):437-44
pubmed: 3661582
Transfusion. 2016 Jun;56(6):1451-8
pubmed: 27079482
J Thromb Haemost. 2017 Jul;15(7):1448-1452
pubmed: 28445600
Transfusion. 2008 Feb;48(2):349-57
pubmed: 18028271
J Thromb Thrombolysis. 2016 Nov;42(4):586-92
pubmed: 27379499
Transfusion. 2017 Aug;57(8):2045-2053
pubmed: 28500622
Intensive Care Med. 2013 Jul;39(7):1272-81
pubmed: 23549631
Intensive Care Med. 1997 Jan;23(1):44-50
pubmed: 9037639
Blood Adv. 2017 Apr 06;1(10):590-600
pubmed: 29296701
Vox Sang. 2013 Nov;105(4):313-8
pubmed: 23662653
Blood. 2010 Feb 25;115(8):1500-11; quiz 1662
pubmed: 20032506
J Clin Apher. 2017 Oct;32(5):311-318
pubmed: 27717013
Intensive Care Med. 2018 Jun;44(6):963-965
pubmed: 29752524
Br J Haematol. 2007 Feb;136(3):451-61
pubmed: 17233847
Transplant Proc. 2002 Nov;34(7):2953-4
pubmed: 12431670
Thromb Res. 2002 Oct 31;107 Suppl 1:S53-7
pubmed: 12379294
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Blood. 2014 Jul 10;124(2):211-9
pubmed: 24859360
Transfusion. 2005 Jan;45(1):41-9
pubmed: 15647017
Br J Haematol. 2006 Jan;132(1):66-74
pubmed: 16371021
Transfusion. 2014 Dec;54(12):3257-9
pubmed: 25496391
Blood. 2003 Jul 1;102(1):60-8
pubmed: 12637323
Am J Hematol. 2015 Jun;90(6):E127-9
pubmed: 25740210
Br J Haematol. 2012 Aug;158(3):323-35
pubmed: 22624596
N Engl J Med. 1998 Nov 26;339(22):1585-94
pubmed: 9828246
Intensive Care Med. 2000 Nov;26(11):1690-3
pubmed: 11193278
Am J Hematol. 2011 Jan;86(1):87-9
pubmed: 20981675
Br J Haematol. 2010 Dec;151(5):488-94
pubmed: 20955397
Br J Haematol. 2013 Nov;163(4):514-9
pubmed: 24111495
J Thromb Thrombolysis. 2018 Jul;46(1):81-83
pubmed: 29564686
Int J Hematol. 2017 Jul;106(1):3-15
pubmed: 28550351
Br J Haematol. 2007 Jan;136(1):146-9
pubmed: 17069579
Intensive Care Med. 2015 Apr;41(4):715-8
pubmed: 25600190
J Thromb Haemost. 2013 Mar;11(3):481-90
pubmed: 23279219
N Engl J Med. 1991 Aug 8;325(6):398-403
pubmed: 2062331
Hematology. 2016 Jun;21(5):311-6
pubmed: 26907228
N Engl J Med. 2016 Feb 11;374(6):511-22
pubmed: 26863353
Clin Exp Immunol. 2015 Mar;179(3):414-25
pubmed: 25339550
Intern Emerg Med. 2014 Apr;9(3):267-72
pubmed: 23054401
J Thromb Haemost. 2015 Feb;13(2):293-302
pubmed: 25403270
Transfusion. 2012 Dec;52(12):2525-32; quiz 2524
pubmed: 22501034
Ann Intern Med. 2003 Jan 21;138(2):105-8
pubmed: 12529092
Haematologica. 1997 Jul-Aug;82(4):429-35
pubmed: 9299856
J Clin Apher. 2013 Feb;28(1):3-10
pubmed: 23420589
Eur J Haematol. 1994 Apr;52(4):222-6
pubmed: 8005232
Chest. 2017 Aug;152(2):424-434
pubmed: 28442312
PLoS One. 2010 Apr 23;5(4):e10208
pubmed: 20436664
Blood. 2016 Jun 16;127(24):3092-4
pubmed: 27060171
Intensive Care Med. 2012 Nov;38(11):1810-7
pubmed: 22797353
Br J Haematol. 2007 Nov;139(3):486-93
pubmed: 17910638
Eur J Haematol. 2016 Aug;97(2):183-91
pubmed: 26608617
J Hematol Oncol. 2008 Dec 01;1:23
pubmed: 19046460
Br J Haematol. 2016 Jun;173(6):821-30
pubmed: 27019232
Am J Pediatr Hematol Oncol. 1984 Winter;6(4):431-9
pubmed: 6398631
Eur J Haematol. 2009 Feb;82(2):83-92
pubmed: 19067741
Medicine (Baltimore). 2003 Jan;82(1):27-38
pubmed: 12544708
Blood. 2012 Jun 14;119(24):5888-97
pubmed: 22547583
Eur J Intern Med. 2015 Nov;26(9):659-65
pubmed: 26293834
Ann Intern Med. 2004 Feb 17;140(4):314-5
pubmed: 14970167
Lancet Haematol. 2017 Apr;4(4):e157-e164
pubmed: 28259520
Arch Surg. 2001 Nov;136(11):1236-8; discussion 1239
pubmed: 11695964
Hematology Am Soc Hematol Educ Program. 2015;2015:637-43
pubmed: 26637782
Haematologica. 2012 Aug;97(8):1181-6
pubmed: 22580997
Transfus Clin Biol. 2017 Sep;24(3):148-153
pubmed: 28645643
Am J Hematol. 2013 Jul;88(7):560-5
pubmed: 23605996
Arch Pathol Lab Med. 2003 Jul;127(7):834-9
pubmed: 12823037
Best Pract Res Clin Haematol. 2009 Dec;22(4):567-76
pubmed: 19959109
Transfusion. 2010 Aug;50(8):1654-64
pubmed: 20412532
Transfus Apher Sci. 2017 Feb;56(1):52-56
pubmed: 28110841
Am J Hematol. 2017 Apr;92(4):381-387
pubmed: 28133771
Nature. 2001 Oct 4;413(6855):488-94
pubmed: 11586351
Transfus Apher Sci. 2017 Aug;56(4):591-594
pubmed: 28764998
Arch Neurol. 2010 Jul;67(7):831-4
pubmed: 20625089
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
N Engl J Med. 1991 Aug 8;325(6):393-7
pubmed: 2062330
Am J Hematol. 1991 Sep;38(1):77
pubmed: 1910257
J Thromb Haemost. 2010 Apr;8(4):631-40
pubmed: 20088924
Br J Haematol. 2014 Feb;164(3):342-51
pubmed: 24172059
Blood. 2014 Jul 10;124(2):204-10
pubmed: 24869941
Br J Haematol. 2009 Feb;144(3):430-3
pubmed: 19036107
Am J Hematol. 2016 Dec;91(12):1246-1251
pubmed: 27643485
Transfusion. 2017 Nov;57(11):2609-2618
pubmed: 28646526
Transfusion. 2015 Jul;55(7):1798-802
pubmed: 25702952
Ann Hematol. 2010 Jun;89(6):591-6
pubmed: 20033409
Neurology. 2009 Jul 7;73(1):66-70
pubmed: 19564586
Curr Opin Hematol. 2005 Sep;12(5):359-63
pubmed: 16093780
N Engl J Med. 1998 Nov 26;339(22):1578-84
pubmed: 9828245
Intensive Care Med. 2005 Jan;31(1):71-8
pubmed: 15580333
Crit Care Med. 2006 Aug;34(8):2127-33
pubmed: 16763519
Transfusion. 2015 Jan;55(1):18-24
pubmed: 24953079
Lancet Haematol. 2016 May;3(5):e237-45
pubmed: 27132698
Blood. 2002 Dec 1;100(12):4033-9
pubmed: 12393397
Blood. 2017 May 25;129(21):2836-2846
pubmed: 28416507
N Engl J Med. 2016 Feb 11;374(6):583-5
pubmed: 26863360
Lancet. 1992 Oct 17;340(8825):977-8
pubmed: 1357383
Transfusion. 2012 Nov;52(11):2436-44
pubmed: 22404639
Transfus Apher Sci. 2011 Oct;45(2):125-31
pubmed: 21903476
Blood. 2015 Jun 18;125(25):3860-7
pubmed: 25784681
Br J Haematol. 2008 Sep;142(5):819-26
pubmed: 18637802
J Thromb Haemost. 2017 Feb;15(2):312-322
pubmed: 27868334
Med Clin North Am. 2017 Mar;101(2):395-415
pubmed: 28189178
Blood. 2001 Sep 15;98(6):1765-72
pubmed: 11535510
Eur J Haematol. 2009 Dec 1;83(6):559-64
pubmed: 19674080
Am J Ther. 2016 Sep-Oct;23(5):e1277-9
pubmed: 26720166
J Thromb Haemost. 2015 Mar;13(3):380-9
pubmed: 25523333
Transfusion. 2015 Oct;55(10):2511-5
pubmed: 26308736
Am J Med. 2013 Nov;126(11):1016.e1-7
pubmed: 23993262
J Thromb Haemost. 2018 Jan;16(1):164-169
pubmed: 29064619
Blood. 2011 Aug 18;118(7):1746-53
pubmed: 21636861
Crit Care Med. 2012 Jan;40(1):104-11
pubmed: 21926591

Auteurs

Elie Azoulay (E)

Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France. elie.azoulay@aphp.fr.

Philippe R Bauer (PR)

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

Eric Mariotte (E)

Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France.

Lene Russell (L)

Department of Intensive Care, Copenhagen University Hospital, RigshospitaletCopenhagen Academy for Medical Simulation and Education, University of Copenhagen, and the Capital Region of Denmark, Copenhagen, Denmark.

Paul Knoebl (P)

Division of Hematology and Hemostasis Department of Medicine 1, Medical University of Vienna, Vienna, Austria.

Ignacio Martin-Loeches (I)

Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, St James Street, Dublin 8, Ireland.

Frédéric Pène (F)

Centre National Maladie Rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, Cochin Hospital and Paris University, Paris, France.

Kathryn Puxty (K)

Department of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK.

Pedro Povoa (P)

Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal.
NOVA Medical School, New University of Lisbon, Lisbon, Portugal.
Center for Clinical Epidemiology and Research, Unit of Clinical Epidemiology, Odense University Hospital Odense, Odense, Denmark.

Andreas Barratt-Due (A)

Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.

Jose Garnacho-Montero (J)

Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain.

Julia Wendon (J)

King's College Hospital, London, UK.

Laveena Munshi (L)

Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.

Dominique Benoit (D)

Ghent University Hospital, Ghent, Belgium.

Michael von Bergwelt-Baildon (M)

Intensive Care in Hematologic and Oncologic Patients, Munich, Germany.
Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany.

Marco Maggiorini (M)

Medical Intensive Care Unit, University Hospital of Zurich, Zurich, Switzerland.

Paul Coppo (P)

Centre National Maladie Rare des Microangiopathies Thrombotiques, Service d'Hématologie, Saint-Antoine Hospital and Paris University, Paris, France.

Spero Cataland (S)

Department of Medicine, Ohio State University, Columbus, OH, USA.

Agnès Veyradier (A)

Centre National Maladies Rares des Microangiopathies Thrombotiques, Service d'Hématologie, Lariboisière Hospital and Paris University, Paris, France.

Andry Van de Louw (A)

Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH